.jpg)
India is considering imposing a Minimum Import Price (MIP) on critical components of medicines to cut the country's dependence on costlier Chinese imports and spur local production.
Roche has reported favorable outcomes from the Phase III IMforte trial involving Tecentriq (atezolizumab) in conjunction with lurbinectedin (Zepzelca®) as a first-line maintenance therapy
 (2).png)
Glenmark Pharmaceuticals has announced that it will shortly introduce zanubrutinib in India, soon after getting its recent approval from the Drugs Controller General of India (DCGI).
 (2).png)
Lupin Limited has obtained approval from the USFDA for its 150 mg, 300 mg, and 600 mg strength Oxcarbazepine ER tablets.
Kyndryl, a top mission-critical enterprise technology services company, has entered into a strategic association with Dr. Reddy's Laboratories, a leading Indian multinational pharmaceutical firm, to transform and simplify the latter's worldwide IT
Servier India, the Indian subsidiary of French multinational pharmaceutical company Servier Group, has rolled out Ivosidenib, an oral targeted treatment for IDH1-mutated acute myeloid leukaemia
 (2).png)
Tracky, a brand of DrStore Healthcare Services and a health tech startup, launched India's first Bluetooth Continuous Glucose Monitor
At the retail price previously authorized by the National Pharmaceutical Pricing Authority ( NPPA), Torrent Pharmaceuticals has been permitted to move the manufacturing of its combination medication for nutritional
 (1).png)
Dr Reddy's Laboratories has made a strategic partnership with global biotechnology company Alvotech for the co-development and commercialization of a biosimilar of Keytruda
A significant drop is being seen in the prices of active pharmaceutical ingredients (API) used for manufacturing drugs, bringing relief to India's pharmaceutical industry. China is largely depended upon the pharma industry for sourcing APIs
, CDSCO.jpg)
